Amended Statement of Beneficial Ownership (3/a)
November 29 2019 - 12:42PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
EPIQ Capital Group, LLC |
2. Date of Event Requiring Statement (MM/DD/YYYY)
5/9/2019
|
3. Issuer Name and Ticker or Trading Symbol
Cortexyme, Inc. [CTRX]
|
(Last)
(First)
(Middle)
ONE LOMBARD STREET, SUITE 200 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner _____ Officer (give title below) ___X___ Other (specify below) / IA/Managing Member 10% owner |
(Street)
SAN FRANCISCO, CA 94111
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY) 6/14/2019
| 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 4338 | I (1) | By Mr. Boeding as Trustee of the Erin Dominy 2019 Irrevocable Trust (2) |
Common Stock | 4338 | I (1) | By Mr. Boeding as Trustee of the Mitsuo Peterson-Cushing 2019 Irrevocable Trust (2) |
Common Stock | 4338 | I (1) | By Mr. Boeding as Trustee for the Spencer Dominy 2019 Irrevocable Trust (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | The reporting persons are EPIQ Capital Group, LLC ("EPIQ") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS ("CTYM") and CTEPQ Partners LLC ("CTEPQ"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 3 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. |
(2) | Form 3 filed 6/14/2019 is being amended to include ownership information relating to the three trusts reported herein. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
EPIQ Capital Group, LLC ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO, CA 94111 |
|
|
| IA/Managing Member 10% owner |
Boeding Chad ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO, CA 94111 |
|
|
| Managing Member of Managing Me |
Signatures
|
Chad Boeding | | 11/29/2019 |
**Signature of Reporting Person | Date |
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Mar 2023 to Mar 2024